ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED-AUCL

930 reported adverse events

These side effects are most commonly reported by patients taking ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED-AUCL:

# Side effect Count
0 HAEMARTHROSIS 368
1 HAEMORRHAGE 262
2 PRODUCT DOSE OMISSION ISSUE 71
3 ARTHRALGIA 53
4 TRAUMATIC HAEMORRHAGE 50
5 LIMB INJURY 46
6 MUSCLE HAEMORRHAGE 45
7 JOINT INJURY 43
8 FALL 31
9 CONTUSION 25
See all common reactions for ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED-AUCL

ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED-AUCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-POLYETHYLENE GLYCOL ANTIBODY ABSENT 1 1.0000
1 ANTI-POLYETHYLENE GLYCOL ANTIBODY 1 0.5000
2 SEIZURE PROPHYLAXIS 1 0.2500
3 ANTI-POLYETHYLENE GLYCOL ANTIBODY PRESENT 2 0.1818
4 VESSEL PUNCTURE SITE INDURATION 1 0.1429
5 HAEMARTHROSIS 368 0.0410
6 TRAUMATIC HAEMORRHAGE 50 0.0266
7 CAUTERY TO NOSE 1 0.0192
8 COAGULATION FACTOR VIII LEVEL DECREASED 3 0.0183
9 VASECTOMY 3 0.0149
See all enriched reactions for ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED-AUCL